Efficacy and toxicity of concurrent chemoradiotherapy in patients with advanced oropharyngeal squamous cell carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 68, Issue 4, 2011, Pages 855-862

  Mori, Makiko ^a   Tsukuda, Mamoru ^a   Matsuda, Hideki ^a   Horiuchi, Choichi ^a   Taguchi, Takahide ^a   Takahashi, Masahiro ^a   Nishimura, Goshi ^a   Komatsu, Masanori ^a   Niho, Tatsuo ^a   Sakuma, Naoko ^a   Miyakoshi, Asako ^a   Isono, Yasuhiro ^a   Iwahana, Sayaka ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Concurrent chemoradiotherapy; Oropharynx; PFML; Squamous cell carcinoma; TPF

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CHEMORADIOTHERAPY; CONTINUOUS INFUSION; DERMATITIS; DIARRHEA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NEPHROTOXICITY; NEUTROPENIA; OROPHARYNX CARCINOMA; PNEUMONIA; PRIORITY JOURNAL; RADIATION DOSE; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; SURVIVAL RATE;

EID: 80054772513     PISSN: 03445704     EISSN: 14320843     Source Type: Journal    
DOI: 10.1007/s00280-010-1551-2     Document Type: Article

References (36)

1. M Al-Sarraf M LeBlanc PG Giri KK Fu J Cooper T Vuong AA Forastiere G Adams WA Sakr DE Schuller JF Ensley 1998 Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099 J Clin Oncol 16 1310 1317 9552031 1:STN:280:DyaK1c3htFOmtQ%3D%3D (Pubitemid 28175745)
2. JP Pignon J Bourhis C Domenge L Designé 2000 Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 949 955 10768432 1:STN:280:DC%2BD3c3ivV2iuw%3D%3D (Pubitemid 30148259)
3. AJ Cmelak S Li MA Goldwasser B Murphy M Cannon H Pinto DI Rosenthal M Gillison AA Forastiere 2007 Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399 J Clin Oncol 25 3971 3977 17761982 10.1200/JCO.2007.10.8951 1:CAS:528: DC%2BD2sXhtFanu73L (Pubitemid 47477276)
4. G Nishimura M Tsukuda Y Mikami H Matsuda C Horiuchi K Satake T Taguchi M Takahashi M Kawakami H Hanamura M Watanabe A Utsumi 2009 The efficacy and safety of concurrent chemoradiotherapy for maxillary sinus squamous cell carcinoma patients Auris Nasus Larynx 36 547 554 19097833 10.1016/j.anl.2008.11.002
5. JP Malone JA Stephens JC Grecula CA Rhoades BA Ghaheri DE Schuller 2004 Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer Head Neck 26 561 572 15229898 10.1002/hed.20012 (Pubitemid 38857097)
6. S Racadot M Mercier S Dussart B Dessard-Diana RJ Bensadoun M Martin E Malaurie V Favrel M Housset C Durdux C Journel G Calais J Huet G Pillet C Hennequin E Haddad C Diana B Blaska-Jaulerry M Henry-Amar P Géhanno F Baillet JJ Mazeron 2008 Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement Radiother Oncol 87 164 172 18222010 10.1016/j.radonc. 2007.12.021
7. MR Posner DM Hershock CR Blajman E Mickiewicz E Winquist V Gorbounova S Tjulandin DM Shin K Cullen TJ Ervin BA Murphy LE Raez RB Cohen M Spaulding RB Tishler B Roth C Viroglio Rdel V Venkatesan I Romanov S Agarwala KW Harter M Dugan A Cmelak AM Markoe PW Read L Steinbrenner AD Colevas CM Norris Jr RI Haddad 2007 TAX 324 Study Group: cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 1705 1715 17960013 10.1056/NEJMoa070956 1:CAS:528:DC%2BD2sXht1ansLvI (Pubitemid 350005152)
8. SF Hall PA Groome J Irish B O'Sullivan 2009 Radiotherapy or surgery for head and neck squamous cell cancer: establishing the baseline for hypopharyngeal carcinoma? Cancer 115 5711 5722 19708030 10.1002/cncr.24635
9. M Haigentz Jr CE Silver J Corry EM Genden RP Takes A Rinaldo A Ferlito 2009 Current trends in initial management of oropharyngeal cancer: the declining use of open surgery Eur Arch Otorhinolaryngol 266 1845 1855 19866522 10.1007/s00405-009-1109-2
10. AY Chen N Schrag Y Hao A Stewart E Ward 2007 Changes in treatment of advanced oropharyngeal cancer, 1985-2001 Laryngoscope 117 16 21 17202924 10.1097/01.mlg.0000240182.61922.31 (Pubitemid 46066056)
11. DA Fein WR Lee WR Amos RW Hinerman JT Parsons WM Mendenhall SP Stringer NJ Cassisi RR Million 1996 Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience Int J Radiat Oncol Biol Phys 34 289 296 8567328 10.1016/0360-3016(95)02028-4 1:STN:280:DyaK287lvVOmtQ%3D%3D (Pubitemid 26031572)
12. CC Wang W Montgomery J Efird 1995 Local control of oropharyngeal carcinoma by irradiation alone Laryngoscope 105 529 533 7760672 10.1288/00005537-199505000-00016 1:STN:280:DyaK2M3otVKltw%3D%3D
13. H Katori M Tsukuda I Mochimatu J Ishitoya S Kawai Y Mikami H Matsuda Y Tanigaki C Horiuchi Y Ikeda T Taguchi M Ono T Yoshida S Hirose Y Sakuma K Yamamoto 2004 Phase 1 trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) Br J Cancer 90 348 352 14735175 10.1038/sj.bjc.6601471 1:CAS:528:DC%2BD2cXksl2ntA%3D%3D (Pubitemid 38250627)
14. H Katori M Tsukuda K Watai 2007 Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) Cancer Chemother Pharmacol 60 3 399 406 17096160 10.1007/s00280-006-0370-y 1:CAS:528:DC%2BD2sXmsVKqu7s%3D (Pubitemid 46944577)
15. T Taguchi M Tsukuda H Katori 2006 Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx Acta Otolaryngol 126 408 413 16608794 10.1080/00016480500401019 1:CAS:528: DC%2BD28XjtlKqtrk%3D
16. H Katori M Tsukuda T Taguchi 2007 Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck Cancer Chemother Pharmacol 59 6 789 794 17053926 10.1007/s00280-006-0335-1 1:CAS:528:DC%2BD2sXjt1WmtLo%3D (Pubitemid 46440602)
17. T Taguchi M Tsukuda Y Mikami H Matsuda Y Tanigaki C Horiuchi G Nishimura J Nagao 2009 Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy Auris Nasus Larynx 36 2 199 204 18632233 10.1016/j.anl.2008.04.003
18. Japan Society for Head and Neck Cancer, Cancer Registry Committee (2007) Report of head and neck cancer registry of Japan clinical statistics of registered patients, 2003. Jpn J Head Neck Cancer 33(suppl):65-73
19. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 19474385 10.3322/caac.20006
20. DJ Adelstein P Lavertu JP Saxton M Secic BG Wood JR Wanamaker I Eliachar M Strome MA Larto 2000 Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck Cancer 88 876 883 10679658 10.1002/(SICI)1097-0142(20000215)88:4<876::AID-CNCR19>3.0.CO;2-Y 1:CAS:528:DC%2BD3cXhtlGntbc%3D (Pubitemid 30091108)
21. AA Forastiere 2008 Chemotherapy in the treatment of locally advanced head and neck cancer J Surg Oncol 97 701 707 18493921 10.1002/jso.21012 1:CAS:528:DC%2BD1cXotFansLw%3D (Pubitemid 351812972)
22. AA Forastiere H Goepfert M Maor TF Pajak R Weber W Morrison B Glisson A Trotti JA Ridge C Chao G Peters DJ Lee A Leaf J Ensley J Cooper 2003 Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2091 2098 14645636 10.1056/NEJMoa031317 1:CAS:528:DC%2BD3sXptlKiu7s%3D (Pubitemid 37464533)
23. RJ Bensadoun K Bénézery O Dassonville N Magné G Poissonnet A Ramaïoli C Lemanski S Bourdin J Tortochaux F Peyrade PY Marcy E Chamorey J Vallicioni H Seng C Alzieu B Géry P Chauvel M Schneider J Santini F Demard G Calais 2006 French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC) Int J Radiat Oncol Biol Phys 64 983 994 16376489 10.1016/j.ijrobp.2005.09.041 1:CAS:528:DC%2BD28Xhslyis7Y%3D
24. F Denis P Garaud E Bardet M Alfonsi C Sire T Germain P Bergerot B Rhein J Tortochaux G Calais 2004 Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma J Clin Oncol 22 69 76 14657228 10.1200/JCO.2004.08.021 (Pubitemid 41095116)
25. G Calais M Alfonsi E Bardet C Sire T Germain P Bergerot B Rhein J Tortochaux P Oudinot P Bertrand 1999 Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma J Natl Cancer Inst 91 2081 2086 10601378 10.1093/jnci/91.24.2081 1:STN:280:DC%2BD3c%2FntFSguw%3D%3D (Pubitemid 30019568)
26. A Cosmidis JP Rame O Dassonville S Temam F Massip G Poissonnet M Poupart P Marandas D De Raucourt 2004 Groupement d'Etudes des Tumeurs de la Tête et du Cou (GETTEC): T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study Eur Arch Otorhinolaryngol 261 276 281 14551793 10.1007/s00405-003-0694-8 (Pubitemid 38680326)
27. SG Urba J Moon PG Giri DJ Adelstein E Hanna GH Yoo M Leblanc JF Ensley DE Schuller 2005 Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial J Clin Oncol 23 88 95 15625363 10.1200/JCO.2005.04.017 (Pubitemid 41702626)
28. JT Parsons WM Mendenhall SP Stringer RJ Amdur RW Hinerman DB Villaret GJ Moore-Higgs BD Greene TW Speer NJ Cassisi RR Million 2002 Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both Cancer 94 2967 2980 12115386 10.1002/cncr.10567 (Pubitemid 34547697)
29. M Tsukuda J Ishitoya H Matsuda C Horiuchi T Taguchi M Takahashi G Nishimura M Kawakami M Watanabe T Niho T Kawano Y Ikeda Y Sakuma O Shiono M Komatsu 2010 Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck Cancer Chemother Pharmacol 66 4 729 736 20033810 10.1007/s00280-009-1217-0 1:CAS:528: DC%2BC3cXoslymtb8%3D
30. DJ Adelstein 2007 Concurrent chemoradiotherapy in the management of squamous cell cancer of the oropharynx: current standards and future directions Int J Radiat Oncol Biol Phys 69 Suppl S37 S39 17848289 10.1016/j.ijrobp.2007.04. 086 (Pubitemid 47369398)
31. ME Zafereo MM Hanasono DI Rosenthal EM Sturgis JS Lewin DB Roberts RS Weber 2009 The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx Cancer 115 5723 5733 19760612 10.1002/cncr.24595
32. AN Reddy DW Eisele AA Forastiere DJ Lee WH Westra JA Califano 2005 Neck dissection followed by radiotherapy or chemoradiotherapy for small primary oropharynx carcinoma with cervical metastasis Laryngoscope 115 1196 1200 15995506 10.1097/01.MLG.0000162643.91849.79 (Pubitemid 40962355)
33. M Tsukuda J Ishitoya Y Mikami H Matsuda C Horiuchi T Taguchi K Satake T Kawano M Takahashi G Nishimura M Kawakami Y Sakuma M Watanabe O Shiono M Komatsu Y Yamashita 2009 Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity Cancer Chemother Pharmacol 64 945 952 19219603 10.1007/s00280-009-0946-4
34. M Machtay J Moughan A Trotti AS Garden RS Weber JS Cooper A Forastiere KK Ang 2008 Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis J Clin Oncol 26 3582 3589 18559875 10.1200/JCO.2007.14.8841 1:CAS:528: DC%2BD1cXpvVWmtLc%3D
35. MR Posner DM Hershock CR Blajman E Mickiewicz E Winquist V Gorbounova S Tjulandin DM Shin K Cullen TJ Ervin BA Murphy LE Raez RB Cohen M Spaulding RB Tishler B Roth C Viroglio Rdel V Venkatesan I Romanov S Agarwala KW Harter M Dugan A Cmelak AM Markoe PW Read L Steinbrenner AD Colevas CM Norris Jr RI Haddad TAX 324 Study Group 2007 Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 17 1705 1715 17960013 10.1056/NEJMoa070956 1:CAS:528:DC%2BD2sXht1ansLvI (Pubitemid 350005152)
36. JB Vermorken E Remenar C van Herpen T Gorlia R Mesia M Degardin JS Stewart S Jelic J Betka JH Preiss D van den Weyngaert A Awada D Cupissol HR Kienzer A Rey I Desaunois J Bernier JL Lefebvre EORTC 24971/TAX 323 Study Group 2007 Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer N Engl J Med 357 17 1695 1704 17960012 10.1056/NEJMoa071028 1:CAS:528:DC%2BD2sXht1ansLvP (Pubitemid 350005151)